Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: A pilot study

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 1, 1997, Pages 157-161

  Lau, Derick H M ^a   Ryu, Janice K ^a   Gandara, David R ^a   Rosenthal, Seth A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Radiation Oncology Center   (United States)

Author keywords

Carboplatin; Etoposide; Poor risk non small cell lung cancer; Radiation

Indexed keywords

CARBOPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS; ETOPOSIDE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; PILOT PROJECTS;

EID: 0031127326     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00249-6     Document Type: Article

References (17)

1. 1. Albain, K. S.; Rusch, V. W.; Crowley, J. J.; Rice, T. W.; Turrisi, A. T., III; Weick, J. K.; Lonchyna, V. A., Presant, C. A.; Mc-Kenna, R. J.; Gandara, D. R.; Fosmire, H.; Taylor, S. A; Stelzer, K. J.; Beasley, K. R., Livingston, R. B. Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB nonsmall-cell lung cancer: Mature results of Southwest oncology Group Phase II study 8805. J. Clin. Oncol. 13:1880-1892; 1995.
2. 2. Albain, K. S. Induction therapy followed by definitive local control for stage III nonsmall-cell lung cancer. Chest 103:43s-50s; 1993.
3. 3. Belani, C. P.; Slawson, R.; Hiponia, D.; Aisner, J. Concurrent carboplatin and radiation for unresectable stage III nonsmall cell lung cancer. Lung Cancer 10:S335; 1994.
4. 4. Bonomi, P. D.; Finkelstein, D. M.; Ruckdeschel, J. C. Combination chemotherapy vs. single agents followed by combination chemotherapy in stage IV nonsmall-cell lung cancer: A study of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 7:1602-1613; 1989.
5. 5. Canetta, R.; Goodlow, J.; Smaldone, L.; Bragman, K.; Rozencweig, M. Pharmacologic characteristics of carboplatin: Clinical experience. In: Bunn, P. A.; Canetta, R.; Ozols, R. F.; Rozencweig, M., eds. Carboplatin (JM-8): Current perspective and future directions. Philadelphia, PA: Lippincott Co.; 1990:19-38.
6. 6. Dillman, R. O.; Seagren, S. L.; Propert, K. J.; Guerra, J.; Eaton, W. L.; Perry, M. C.; Carey, R. W.; Frei, E. F., III; Green, M. R. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III nonsmall-cell lung cancer. N. Engl. J. Med. 323:945-945; 1990.
7. 7. Feld. R.; Borges, M.; Giner, V. Prognostic factors in nonsmall cell lung cancer. Lung Cancer 11(Suppl. 3):S10-S23; 1994.
8. 8. Friess, G. G.; Baikadi, M.; Harvey, W. H. Concurrent cisplatin and etoposide with radiotherapy in locally advanced nonsmall cell lung cancer. Cancer Treat Report 71:681-684; 1990.
9. 9. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481, 1958.
10. 10. Klastersky, J.; Sculier, J. P.; Lacroix, H. E. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced nonsmall-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J. Clin. Oncol. 8:1556-1562; 1990.
11. 11. Le Chevalier, T.; Arriagada, R.; Quoix, E.; Ruffie, P.; Martin, M.; Tarayre, M.; Lacombe-Terrier, M-J.; Douillard, J.-Y.; Laplanche, A. Radiotherapy alone vs. combined chemotherapy and radiotherapy in nonresectable nonsmall-cell lung cancer: First analysis of a randomized trial in 353 patients. J. Natl. Cancer Inst. 83:417-423; 1991.
12. 12. Marino, P.; Preatoni, A.; Cantoni, A. Randomized trials of radiotherapy alone vs. combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysis. Cancer 76:593-601; 1995.
13. 13. Mountain, C. F. A new international staging system for lung cancer. Chest 89:225S-233S; 1986.
14. 14. Recine, D.; Rowland, K.; Reddy, S.; Lee, M. S.; Bonomi, P.; Taylor, S., IV; Faber, L. P.; Warren, W.; Kittle, C. F.; Hendrickson, F. R. Combined modality therapy for locally advanced nonsmall cell lung carcinoma. Cancer 66:2270-2278; 1990.
15. 15. Rosenow, E. C., III. Lung cancer: Update on screening, diagnosis, and prognosis. Consultant 35:1355-1371, 1995.
16. 16. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Emami, B.; Curran, W. J.; Byhardt, R. W.; Turrisi, A. T.; Dar, A. R.; Cox, J. D. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a Phase III trial in regionally advanced, unresectable nonsmall-cell lung cancer. J. Natl. Cancer Inst. 87:198-205; 1995.
17. 17. Schaake-Koning, C.; van den Bogaert, W.; Dalesio, O.; Festen, J.; Hoogenhout, J.; van Houtte, P.; Kirpatrick, A.; Koolen, M.; Maat, B.; Nijs, A.; Renaud, A.; Rodrigus, P.; Schuster-Uitterhoeve, L.; Sculier, J.-P.; van Zandwijk, N.; Bartelink, H. Effects of concomitant cisplatin and radiotherapy on inoperable nonsmall-cell lung cancer. N. Engl. J. Med. 326:524-530; 1992.